🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles privately for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing customers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in users injecting substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking fines, legal action or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has taken down violative content and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Research also discovered groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, positive testimonials and step-by-step instructions for preparing or injecting at home.

Within moments of entering one group, a vendor posted contact information, where most transactions take place. The vendor sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Item Details and Pricing

Within these communities, messages show dark colored parcels with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service stated it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to possibly significant health risks”.